Current Perspectives in Haematological Malignancies - Leeds

Current Perspectives in Haematological Malignancies - Leeds is organized by Hartley Taylor Medical Communications Ltd and would be held on Oct 11, 2016 at Hilton Leeds City, Leeds, England, United Kingdom.

Speakers Topics:

Myeloma, upfront treatment of newly diagnosed patients - Graham Jackson

Myeloma, relapsed refractory – are combinations the future? - Gordon Cook and Karthik Ramasamy

ALL update – Andrew McMillan

New agents in CLL – what drug when? - George Follows

CML update – where are we with treatments and side effects – Steve O’Brien

Targeted therapy in AML - Mike Dennis

Novel agents in lymphoma where are we going? - Simon Rule

Future of immunotherapy: what are the check - point inhibitors, how do they work? – Tim Illidge

What is the role of radiotherapy, interesting case studies - Tim Illidge and Stephen Robinson

Viral infections in the immunocompromised – Anne Parke

Haematological Malignancies - T-Cell Therapies; CAR-T cells & TCR gene-modified T cells – Emma Morris

Registration Fee: £60.00 + VAT